長庚醫療財團法人林口長庚紀念醫院是成立於1978年12月1日的私立綜合醫院。到2019年底為止，林口長庚紀念醫院是全世界床位數第二多的醫院。

During the past decade, Linkou Chang Gung Memorial Hospital conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 25 clinical trials were completed, i.e. on average, 32.9% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 18 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Linkou Chang Gung Memorial Hospital" #1 sponsor was "Chang Gung Memorial Hospital" with 41 trials, followed by "Boehringer Ingelheim" with 11 trials sponsored, "Takeda" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "National Health Research Institutes, Taiwan" with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Linkou Chang Gung Memorial Hospital" #1 collaborator was "Chang Gung Memorial Hospital" with 9 trials as a collaborator, "Ministry of Science and Technology, Taiwan" with 6 trials as a collaborator, "China Medical University Hospital" with 4 trials as a collaborator, "Mackay Memorial Hospital" with 3 trials as a collaborator and "National Cheng-Kung University Hospital" with 3 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Linkou Chang Gung Memorial Hospital" are "Stroke" (9 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Atrial Fibrillation" (3 trials), "Cerebrovascular Accident" (3 trials) and "Chronic Hepatitis B" (3 trials). Many other conditions were trialed in "Linkou Chang Gung Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Linkou Chang Gung Memorial Hospital" are "Drug" (50 trials), "Device" (21 trials), "Behavioral" (13 trials), "Other" (11 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Lansoprazole" (4 trials), "Lansoprazole Placebo" (4 trials), "Afatinib" (2 trials) and "Avelumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Linkou Chang Gung Memorial Hospital" are 103 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Linkou Chang Gung Memorial Hospital". 1 are not yet recruiting, 26 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Linkou Chang Gung Memorial Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Linkou Chang Gung Memorial Hospital, 4 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 36 trials that are defined as “Not Applicable".